Literature DB >> 7822886

Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status.

M A Compton1.   

Abstract

The objective of this study was to describe pain tolerance in drug abusers. Research suggests that drug dependence and pain perception share common neuroanatomical and neurophysiological substrates; thus the abuse of psychoactive drugs was hypothesized to relate to pain tolerance. We examined cold-pressor pain tolerance in 122 male, current and former opioid and cocaine abusers, across use status and primary drug of abuse. Descriptive analyses showed that the ratio of pain-sensitive to pain-tolerant persons was considerably higher than that described in the normative cold-pressor pain literature. Two-way analysis of variance revealed a significant main effect for using status, indicating that current drug use is associated with decreased pain tolerance. The main effect for drug type approached significance, implying that persons who abuse opioids manifest less pain tolerance than cocaine users. The findings emphasize the importance of studying pain tolerance and drug abuse as interrelated phenomena.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7822886     DOI: 10.1016/0885-3924(94)90203-8

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  33 in total

1.  Shared mechanisms for opioid tolerance and a transition to chronic pain.

Authors:  Elizabeth K Joseph; David B Reichling; Jon D Levine
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

Review 2.  Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.

Authors:  Daniel P Alford; Peggy Compton; Jeffrey H Samet
Journal:  Ann Intern Med       Date:  2006-01-17       Impact factor: 25.391

3.  An assessment of factorial structure and health-related quality of life in problem drug users using the Short Form 36 Health Survey.

Authors:  Angela Buchholz; Anneke Krol; Fred Rist; Pythia T Nieuwkerk; Gerard M Schippers
Journal:  Qual Life Res       Date:  2008-07-12       Impact factor: 4.147

4.  Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients.

Authors:  Caroline A Arout; Andrew J Waters; R Ross MacLean; Peggy Compton; Mehmet Sofuoglu
Journal:  Psychopharmacology (Berl)       Date:  2018-12-18       Impact factor: 4.530

5.  Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy.

Authors:  Peggy Compton; Catherine P Canamar; Maureen Hillhouse; Walter Ling
Journal:  J Pain       Date:  2012-03-15       Impact factor: 5.820

6.  Clarifying the roles of homeostasis and allostasis in physiological regulation.

Authors:  Douglas S Ramsay; Stephen C Woods
Journal:  Psychol Rev       Date:  2014-04       Impact factor: 8.934

7.  Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving.

Authors:  Zhen-Yu Ren; Jie Shi; David H Epstein; Jun Wang; Lin Lu
Journal:  Psychopharmacology (Berl)       Date:  2009-01-27       Impact factor: 4.530

8.  Days of heroin use predict poor self-reported health in hospitalized heroin users.

Authors:  Lidia Z Meshesha; Judith I Tsui; Jane M Liebschutz; Denise Crooks; Bradley J Anderson; Debra S Herman; Michael D Stein
Journal:  Addict Behav       Date:  2013-08-14       Impact factor: 3.913

9.  Reduced cold pain tolerance in chronic pain patients following opioid detoxification.

Authors:  Jarred Younger; Peter Barelka; Ian Carroll; Kim Kaplan; Larry Chu; Ravi Prasad; Ray Gaeta; Sean Mackey
Journal:  Pain Med       Date:  2008-06-18       Impact factor: 3.750

10.  The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males.

Authors:  David Andrew Tompkins; Michael T Smith; George E Bigelow; Ruin Moaddel; Swarajya Lakshmi Vatem Venkata; Eric C Strain
Journal:  Clin J Pain       Date:  2014-01       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.